The AB-Biotics Personalized Medicine Platform (NEUROFARMAGEN) Increases Psychiatric Treatment Efficacy by 67%

12/07/2019

At a meeting held yesterday, the Board of Directors of the Company has adopted, unanimously (the directors designated by Kaneka Europe Holding Company NV –“Kaneka” abstaining from participating), among others, the following...

10/07/2019

AB-Biotics announced today that Kaneka Europe Holding Company has launched a voluntary takeover bid for 100% of the share capital of the company excluding the shares it already possesses, consequently valuing the...

26/06/2019

Today, June 27th, we join the entire world’s scientific community in celebrating #WorldMicrobiomeDay. The microbiome is the group of microorganism colonies that live inside humans (bacteria, fungi, viruses, etc.). Researchers are exploring...

20/06/2019

AB-Biotics will actively participate in the IPA World Congress + Probiota Americas organized by NutraIngredients-USA, which will take place in Vancouver, Canada, from June 24th to 26th. The congress is the premier...

10/06/2019

AB-Biotics attended for the first time to ESPGHAN 2019 Annual Meeting (The European Society for Paediatric Gastroenterology Hepatology and Nutrition) held last week in Glasgow (Scottland). ESPGHAN is a multi-professional organization whose...